Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260299 · ClinicalTrials.gov registry record
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
A clinical trial, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT00260299: Clinical Trial study, sponsored by Oregon Health and Science University.
NCT00260299 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260299 was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patients with MKD (mevalonic aciduria or hyperimmunoglobulinemia with periodic fever syndrome (HIDS)) may be eligible for a research study conducted at Oregon Health \& Science University (OHSU) in Portland, Oregon USA. The purpose of the study is to find out more about how these diseases affect body chemistry and health. The researchers also want to find out how cholesterol in the diet affect blood cholesterol and how the body handles cholesterol. This is a short-term and long-term dietary study. The long-term goal of this research is to see if controlling dietary cholesterol can decrease any of the symptoms of the diseases. The study could involve up to 12 one-week admissions to OHSU over the course of 5 years.
Primary Outcome
blood levels of cholesterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-02 |
| Est. Completion | 2016-01-31 |
Why NCT00260299 stopped before completion
NCT00260299 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00260299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00260299 about?
NCT00260299 is a clinical study titled "Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency". Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patients with MKD (mevalonic aciduria or hyperimmunoglobulinemia with periodic fever syndrome (HIDS)) may be eligible for a research study conduct...
What is the current status of trial NCT00260299?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2005-02. Estimated completion is 2016-01-31.
Who is sponsoring clinical trial NCT00260299?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia